Outsourced Pharma White Papers

  1. Overcoming Challenges To High-Concentration Formulation Development 3/25/2025

    Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.

  2. Predictive Modeling Of Viscosity Behavior Using Artificial Neural Networks 9/11/2023

    Discover a modeling approach employing artificial neural networks using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.

  3. Mastering Technology Transfers: Our Blueprint For Success 4/16/2025

    Uncover how this expert approach to process transfer supports reliable, scalable commercial manufacturing in the rapidly growing biopharmaceutical market.

  4. Is Sustainability The Key To Agile Biopharma Manufacturing? 3/18/2025

    In biologics manufacturing, change is constant. Discover how new innovations and a focus on sustainability have gotten 62% of executives to prioritize eco-friendly practices, which reflects a commitment to long-term viability.

  5. Innovation In Filtration 3/18/2025

    Filtration is essential in various applications, from lab-scale tasks to GMP production, that removes contaminants to ensure safety and efficiency. Explore how its simplicity and reliability make it indispensable across industries.

  6. Nose To Brain (N2B) Drug Delivery – Benefits And Challenges 11/20/2024

    Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).

  7. Optimizing Poloxamer 188 1/13/2025

    Poloxamer 188 stabilizes proteins in liquid formulations and protects cells from shear stress. Molecular weight and hydrophobicity variations influence its effectiveness in different biopharmaceutical applications.

  8. The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics 5/16/2024

    Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Review the challenges of transitioning a promising drug candidate.

  9. Cell Line Development: The Linchpin In Biotherapeutic Development 1/4/2024

    Review key factors for building a reliable CLD strategy, and learn how the right CDMO can help you achieve the high quality, high yield, and speed needed to successfully bring a biologic to market.

  10. Antibody-Drug Conjugates – Catalysts For Chemistry 5/16/2024

    Review the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development.